Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentendoplasmic reticulum exit site

CTAGE9 MIA2 SEC24A

1.38e-0442503GO:0070971
DomainHomeobox_KN

TGIF2LY TGIF2LX

8.23e-0417472PF05920
DomainHomeobox_KN_domain

TGIF2LY TGIF2LX

8.23e-0417472IPR008422
PathwayREACTOME_CARGO_CONCENTRATION_IN_THE_ER

CTAGE9 MIA2 SEC24A

8.67e-0536343MM15300
PathwayREACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ

RBBP8 POLQ

3.67e-0412342M27569
PathwayREACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ

RBBP8 POLQ

3.67e-0412342MM15282
PathwayREACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT

CTAGE9 MIA2 COPB1 SEC24A

6.83e-04168344MM14785
PathwayREACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA

TUT7 DPPA2

7.51e-0417342M48025
Pubmed

cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.

CTAGE9 MIA2 CTAGE3P

2.96e-08551312839582
Pubmed

The human-specific Yp11.2/Xq21.3 homology block encodes a potentially functional testis-specific TGIF-like retroposon.

TGIF2LY TGIF2LX

2.11e-06251212226713
Pubmed

Association of TGIFLX/Y mRNA expression with azoospermia in infertile men.

TGIF2LY TGIF2LX

2.11e-06251218384077
Pubmed

Expression of a novel TGIF subclass homeobox gene, Tex1, in the spermatids of mouse testis during spermatogenesis.

TGIF2LY TGIF2LX

2.11e-06251211960710
Pubmed

Association of TGIFLX/Y mRNA expression with prostate cancer.

TGIF2LY TGIF2LX

2.11e-06251218663611
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

EFCAB5 MIA2 DNAJC10 RBBP8 DPPA2 MACF1 ALAS2 RRBP1 POLQ DTHD1 DOP1A

6.19e-061442511135575683
Pubmed

Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance.

CTAGE9 MIA2

1.26e-05451233718348
Pubmed

Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes.

CTAGE9 MIA2

1.26e-05451212586826
Pubmed

Molecular cloning of a mouse scavenger receptor with C-type lectin (SRCL)(1), a novel member of the scavenger receptor family.

TGIF2LY TGIF2LX

1.26e-05451211718900
Pubmed

Mea6 controls VLDL transport through the coordinated regulation of COPII assembly.

CTAGE9 MIA2

1.26e-05451227311593
Pubmed

MEA6 Deficiency Impairs Cerebellar Development and Motor Performance by Tethering Protein Trafficking.

CTAGE9 MIA2

1.26e-05451231244610
Pubmed

And-1 coordinates with CtIP for efficient homologous recombination and DNA damage checkpoint maintenance.

WDHD1 RBBP8

1.26e-05451227940552
Pubmed

Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sites.

CTAGE9 MIA2

1.26e-05451221807889
Pubmed

A tissue-specific atlas of mouse protein phosphorylation and expression.

CTAGE9 MIA2

2.10e-05551221183079
Pubmed

Specific phosphopeptide enrichment with immobilized titanium ion affinity chromatography adsorbent for phosphoproteome analysis.

CTAGE9 MIA2

2.10e-05551218630941
Pubmed

Expression pattern of TG-interacting factor 2 during mouse development.

TGIF2LY TGIF2LX

2.10e-05551215749073
Pubmed

Large scale localization of protein phosphorylation by use of electron capture dissociation mass spectrometry.

CTAGE9 MIA2

2.10e-05551219131326
Pubmed

Characterization and expression pattern of the novel MIA homolog TANGO.

CTAGE9 MIA2

2.10e-05551215183315
Pubmed

Mea6/cTAGE5 cooperates with TRAPPC12 to regulate PTN secretion and white matter development.

CTAGE9 MIA2

2.10e-05551238439956
Pubmed

And-1 is required for homologous recombination repair by regulating DNA end resection.

WDHD1 RBBP8

2.10e-05551227940557
Pubmed

cTAGE5 deletion in pancreatic β cells impairs proinsulin trafficking and insulin biogenesis in mice.

CTAGE9 MIA2

4.41e-05751229133483
Pubmed

Misexpression of MIA disrupts lung morphogenesis and causes neonatal death.

CTAGE9 MIA2

7.54e-05951218342301
Pubmed

MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity.

GTSE1 MACF1 PPP6R2

8.22e-055751329089450
Pubmed

Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice.

CTAGE9 MIA2

1.63e-041351211839810
Pubmed

An approach based on a genome-wide association study reveals candidate loci for narcolepsy.

HIPK3 CERKL TRIM69 OXA1L

1.87e-0419351420677014
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

BDP1 NDC80 RBBP8 KDM2B MACF1 PPP6R2

2.15e-0458851638580884
Pubmed

cTAGE5/MEA6 plays a critical role in neuronal cellular components trafficking and brain development.

CTAGE9 MIA2

2.19e-041551230224460
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

TUT7 CRYBG1 RRBP1 GCN1

2.23e-0420251433005030
Pubmed

The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.

COPB1 DPPA2 KDM2B HAL GCN1

2.85e-0439651526687479
Pubmed

Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.

MIA2 WDHD1 COPB1 PPP6R2 GCN1

2.95e-0439951537536630
Pubmed

Serological detection of cutaneous T-cell lymphoma-associated antigens.

MIA2 CTAGE3P

3.18e-041851211149944
Pubmed

The ULK1-FBXW5-SEC23B nexus controls autophagy.

SEC24A KDM2B

3.94e-042051230596474
Pubmed

Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

BDP1 TUT7 DUSP16

4.60e-0410251311214970
Pubmed

Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

CEP162 CHSY1 SEZ6L

4.60e-0410251310231032
Pubmed

The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.

COPB1 GTSE1 RRBP1 GCN1

5.46e-0425651433397691
Pubmed

CRISPR/Cas9-mediated genome editing reveals 30 testis-enriched genes dispensable for male fertility in mice†.

TGIF2LY TGIF2LX

1.15e-033451231201419
Pubmed

rec-YnH enables simultaneous many-by-many detection of direct protein-protein and protein-RNA interactions.

RBBP8 GTSE1 KIF19

1.20e-0314251330217970
Pubmed

Diversification of stem cell molecular repertoire by alternative splicing.

EFCAB5 CERKL

1.22e-033551216183747
Pubmed

STRAP regulates alternative splicing fidelity during lineage commitment of mouse embryonic stem cells.

CTAGE9 MIA2

1.29e-033651233230114
InteractionMAPRE3 interactions

NDC80 CEP162 TUT7 GTSE1 KIF19 MACF1

1.50e-05230476int:MAPRE3
GeneFamilyCTAGE family

CTAGE9 MIA2 CTAGE3P

2.05e-0615313907
GeneFamilyTALE class homeoboxes and pseudogenes

TGIF2LY TGIF2LX

9.01e-0426312526
ToppCellfacs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VSTM4 TRIM69 DUSP16 KIF19 ALAS2

1.13e-0616151560f433eab9d5531bdf6aa86b0265f20b866b904c
ToppCellFetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

WDR93 CERKL TMEM232 KIF19 DTHD1

2.36e-061875159e10ed56090d82589bc457788282f664b70ace4b
ToppCellEpithelial-ciliated_cell|World / Lineage, Cell type, age group and donor

WDR93 CERKL TMEM232 KIF19 DTHD1

2.43e-0618851561a459f3fe57e5728efc72637ff2edc2d343492b
ToppCellChildren_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

WDR93 CERKL TMEM232 KIF19 DTHD1

2.43e-061885152b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCellChildren_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

WDR93 CERKL TMEM232 KIF19 DTHD1

2.49e-0618951568a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCellNS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

WDR93 CERKL TMEM232 KIF19 DTHD1

2.83e-061945151ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCellCOVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations)

WDHD1 NDC80 GTSE1 ALAS2 POLQ

2.90e-06195515764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCellControl-T/NK_proliferative|Control / Disease condition and Cell class

WDHD1 NDC80 RBBP8 GTSE1 POLQ

2.98e-061965157b7bc25aef49bfd64f79303a92d527bf8188f7a6
ToppCellCOVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class

WDHD1 NDC80 RBBP8 GTSE1 POLQ

3.05e-06197515718a84e9a8248080f2d964e7c6a3ba183ece9592
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WDHD1 NDC80 RBBP8 GTSE1 POLQ

3.21e-06199515123fbf2122aa221d8cbf3aef9361ba0982c07695
ToppCellCOVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class

WDHD1 NDC80 RBBP8 GTSE1 POLQ

3.21e-06199515ddae7fe7633661f15d3c79f5187415ffbfecce67
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

WDHD1 NDC80 RBBP8 GTSE1 POLQ

3.21e-06199515e98ff036d04fc78dffef156bdc0d644532274067
ToppCellCOVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class

WDHD1 NDC80 RBBP8 GTSE1 POLQ

3.21e-061995152e9ee10a069afca5dbd9f0863cf90a66db1a6ffb
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WDHD1 NDC80 RBBP8 GTSE1 POLQ

3.21e-061995156b1304417cf9c44ca70d2bfc2b5acc1a206f25b6
ToppCellLPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CERKL WDHD1 NDC80 GTSE1 POLQ

3.21e-0619951598575fcce726589e93fbb4df1aab03e57cb56076
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

WDHD1 NDC80 RBBP8 GTSE1 POLQ

3.21e-061995157feedb0bf84a3361c8ab5b6674ff64e8ff140c23
ToppCellsevere-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

WDHD1 NDC80 RBBP8 GTSE1 POLQ

3.28e-06200515d341f4e500377a5bef82c24bf64704b981053336
ToppCellsevere-T/NK_proliferative|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

WDHD1 NDC80 RBBP8 GTSE1 POLQ

3.28e-062005159d6e7e2d6cfa8c96bbb5c187815df96ecaa5475c
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

WDR93 CERKL TMEM232 KIF19 DTHD1

3.28e-0620051506ce6e03498ba38ef6a06eaf2731e3b2eeda59eb
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Severe / Disease, condition lineage and cell class

WDHD1 NDC80 RBBP8 GTSE1 POLQ

3.28e-062005150892603e604c2a945dd720685d45970f855bd5d3
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

WDR93 CERKL TMEM232 KIF19 DTHD1

3.28e-06200515926a7ea94b5908aebf103893ea83ce9d25285b65
ToppCellCOVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass

WDHD1 NDC80 RBBP8 GTSE1 POLQ

3.28e-062005157e4c0db43a03ca11380a54f44a3cf1991e055b80
ToppCellTracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

WDR93 CERKL KIF19 DPPA2 DTHD1

3.28e-06200515af6a551f83808c1c839df7ba7b1702ca28ea6e1b
ToppCellCOVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass

WDHD1 NDC80 RBBP8 GTSE1 POLQ

3.28e-062005159775ca7dedb76fcbb74f80f86b33c94e394c320a
ToppCellTracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

WDR93 CERKL KIF19 DPPA2 DTHD1

3.28e-0620051573ac1cf40ddd764be1100cbfaaa29563665457d8
ToppCellLPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

EFCAB5 NDC80 GTSE1 POLQ

1.45e-05129514739b263296c28554967362060b154f7a95e1341d
ToppCellLPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

EFCAB5 NDC80 GTSE1 POLQ

1.50e-05130514615c233c7c2600c1c2bc5cf5b1c501fc474564ef
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-7|TCGA-Brain / Sample_Type by Project: Shred V9

WDHD1 NDC80 DUSP16 POLQ

1.79e-05136514d94f0fbeb7b80d4cf0687d1924ebf8f9dd07358c
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

GTSE1 CRYBG1 POLQ KCTD18

2.49e-0514851418cfecd6ae20edb74f5d44ba759909df356acf3a
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

WDHD1 NDC80 DPPA2 POLQ

4.18e-05169514e7514956b2e4298222ec443f98b2f5289451786e
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NDC80 GTSE1 AKR1D1 POLQ

4.18e-05169514e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

DUSP16 CRYBG1 MACF1 DTHD1

4.38e-051715142e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

NDC80 RBBP8 GTSE1 POLQ

4.79e-051755140b1aaa028ba844d4bcb4509fdab8bee648373935
ToppCellPCW_13-14-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

WDR93 CERKL KIF19 DTHD1

4.79e-05175514c82ec6deb6ccdd991a69a62b6d62d5b14c803d7a
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

WDHD1 NDC80 GTSE1 POLQ

4.79e-05175514f7d191cde68de8f3457fa62b1df53b6d0dbe5001
ToppCellPCW_13-14-Epithelial-Epithelial_ciliated|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

WDR93 CERKL KIF19 DTHD1

4.79e-05175514b1369d2b74f461e6822d0c33e9b50fe0dfbceb54
ToppCell368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

NDC80 RBBP8 GTSE1 POLQ

5.01e-0517751426c25d10aa511b64cc7db43a8deea7b5d31bca96
ToppCellFetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CERKL TMEM232 KIF19 DTHD1

5.12e-05178514de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

WDHD1 NDC80 GTSE1 POLQ

5.23e-0517951480112c686a8f85ad5e3cda6e3f3d3d51cf688092
ToppCellfacs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

VSTM4 HTRA3 PLCD1 SEZ6L

5.46e-05181514ebf1ae963a2b22e1772752ed85a4fb0e546d377e
ToppCellFetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CERKL TMEM232 KIF19 DTHD1

5.46e-05181514dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue

WDHD1 NDC80 GTSE1 POLQ

5.70e-05183514a48a6313f2f144586951cece97ec31f6d72361df
ToppCell343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

WDHD1 NDC80 GTSE1 POLQ

5.82e-051845146b2449ac65a2322aa0479fba0d89828f243aabbe
ToppCell343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

WDHD1 NDC80 GTSE1 POLQ

5.82e-05184514e90622b82fa7f16a1faaf7a4724c958f2d83341d
ToppCellControl-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations)

WDHD1 NDC80 GTSE1 POLQ

5.95e-051855149766216b41ee62bbac4caa25cb98ec5627a24075
ToppCellFetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

WDR93 CERKL KIF19 DTHD1

5.95e-051855143e39a3cb534dfe2301930f3e2f7e8cefb522c158
ToppCellNS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

WDR93 CERKL TMEM232 KIF19

5.95e-051855145e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCellCiliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

WDR93 TMEM232 KIF19 DTHD1

5.95e-05185514f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCellNS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CERKL TMEM232 KIF19 DTHD1

6.07e-0518651476033438426d8f9c72cd6691a7baf92104c9f03d
ToppCellAdult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor

WDR93 CERKL TMEM232 DTHD1

6.33e-0518851434b11f72ca73153d02edcd09b38983ad1a504659
ToppCell367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

RBBP8 GTSE1 ALAS2 POLQ

6.33e-05188514f5102e8d95506c25c675094b86162a6a50087b64
ToppCelldroplet-Lung-nan-21m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WDHD1 NDC80 FGF13 POLQ

6.33e-0518851461ae7405ab56570409bf35382dc0a038e4137c15
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

WDHD1 NDC80 GTSE1 POLQ

6.46e-05189514fd8834d1feb7f63911c5fa51efb1f679a8baddeb
ToppCellTransplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

WDR93 TMEM232 KIF19 DTHD1

6.46e-05189514dc440015949a768188c67661b6be63b1ead1a0f0
ToppCellcellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

WDR93 CERKL TMEM232 DTHD1

6.46e-05189514a3cd4c2da4feb9bdcd8957f3e344d095da1367b8
ToppCellControl-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

WDHD1 NDC80 GTSE1 POLQ

6.46e-051895141e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCellAdult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor

WDR93 CERKL TMEM232 DTHD1

6.46e-05189514b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCellCOVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type

WDR93 CERKL TMEM232 DTHD1

6.46e-0518951427329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCellcellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

WDR93 CERKL TMEM232 DTHD1

6.46e-0518951493b1026bb1ba759e5704561c9a5de14a30c08894
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

WDHD1 NDC80 GTSE1 POLQ

6.59e-05190514e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCellpdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

WDHD1 NDC80 GTSE1 POLQ

6.59e-05190514d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCellTransplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

WDR93 TMEM232 KIF19 DTHD1

6.59e-05190514a90a38fccdbf75a286b4d258fc54920c02b282f7
ToppCellcellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

WDR93 CERKL TMEM232 DTHD1

6.59e-0519051417829f4de31b3d9e4d71ba4817d18842aa699773
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

WDHD1 NDC80 RBBP8 GTSE1

6.73e-0519151450854384fdaa0efa2e3227659d544ed09ac102f2
ToppCellCOVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type

RBBP8 CHSY1 CRYBG1 FGF13

6.87e-05192514d32ae226d95b4b6adb99d14b602be09b661d4cd9
ToppCellCOVID-19_Severe-Plasmablast|World / disease group, cell group and cell class

SEC24A GTSE1 RRBP1 POLQ

6.87e-05192514a333053fe2bd206c32790916bfc5fce904ab7f57
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

WDHD1 GTSE1 NDST4 POLQ

7.01e-05193514bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCellhuman_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

WDHD1 NDC80 GTSE1 POLQ

7.01e-051935144b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WDHD1 NDC80 GTSE1 POLQ

7.15e-05194514f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

WDHD1 NDC80 GTSE1 POLQ

7.15e-0519451417af04acd54dd6a895a966cbb4422de25dc4f1e6
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

WDHD1 NDC80 GTSE1 POLQ

7.15e-05194514a75ecd0b0a928d4646602f7d16a645f6b3df3af5
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WDHD1 NDC80 GTSE1 POLQ

7.15e-0519451417744fd6645cf5a447a01a83f07e8d305c2bcd9c
ToppCelldroplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BDP1 TUT7 MACF1 RRBP1

7.15e-05194514e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SEC24A GTSE1 RRBP1 POLQ

7.15e-05194514ffba703f61faaac8b4b9a5e46cd335214303de7b
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

WDHD1 NDC80 GTSE1 POLQ

7.15e-05194514635d0e88f9c542a1d9363066c6cdbc6e44db76c1
ToppCellControl-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class

WDHD1 NDC80 GTSE1 POLQ

7.15e-051945149bbb124001fba7450f4639f47f9b720a483e7242
ToppCellControl-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type

WDHD1 NDC80 GTSE1 POLQ

7.15e-05194514844731b7943d1cfca819b7b89e4e62067bfa0230
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

WDHD1 NDC80 GTSE1 POLQ

7.15e-05194514e14f66f7584909621b776292fbd52808273fd2ee
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

WDHD1 NDC80 DTHD1 DOP1A

7.15e-051945148f4b63b0b9a40765205e4ca6bd94a675a83dbe3d
ToppCell18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class

VSTM4 HTRA3 FGF13 RRBP1

7.29e-05195514f86737bff21d81673238813df61a15cfe88d0b15
ToppCellHealthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class

WDHD1 NDC80 GTSE1 POLQ

7.29e-05195514957458fdc39723f4a31bd7fd3ce32891aa3fd462
ToppCellInfluenza_Severe-T/NK_proliferative|World / Disease group and Cell class

WDHD1 NDC80 GTSE1 POLQ

7.29e-051955146f079c2d7d08110a5e1822ea861b8037eb3f62c9
ToppCellHealthy-T/NK_proliferative|Healthy / disease group, cell group and cell class

WDHD1 NDC80 GTSE1 POLQ

7.44e-0519651491e44aabb2e85dcc77ddae6f7e000118d45d1de6
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

WDHD1 NDC80 GTSE1 POLQ

7.44e-051965141d2e0b328eb822db7521b5f5724d4bd17c0bad5f
ToppCellmild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

WDHD1 NDC80 RBBP8 GTSE1

7.44e-05196514b1d9866d5dfaefdb8bedaf01a750d97987acb3d1
ToppCellcontrol-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

WDHD1 NDC80 RBBP8 GTSE1

7.44e-05196514886f7c865b086d6ebb4a1746865c30af6bbed345
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

WDHD1 NDC80 GTSE1 POLQ

7.58e-0519751421861d8b389fafbdb7c3499684c9b6deee3dbd5e
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

WDHD1 NDC80 GTSE1 POLQ

7.58e-051975148b616cde333bdbc0c591035ad9e4949155866245
ToppCellsevere_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2)

WDHD1 NDC80 GTSE1 POLQ

7.58e-05197514189d97a6c2ff8803db8cc05e205c9d88dac3911f
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

WDHD1 NDC80 GTSE1 POLQ

7.58e-051975144b13335a43b9d6abc8e542e72440da7feb82fbe6
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

WDHD1 NDC80 GTSE1 POLQ

7.58e-05197514d669d90c3f9e98b41bcbc49dbdc5698e0b42597c
ToppCellHealthy-T/NK_proliferative|World / disease group, cell group and cell class

WDHD1 NDC80 GTSE1 POLQ

7.58e-05197514e90be1e7e02f736b6aab14010a912b592d6f1e80
ToppCellHealthy/Control-T/NK_proliferative|World / Disease group and Cell class

WDHD1 NDC80 GTSE1 POLQ

7.58e-051975144a4d3083938783d6f5b87da02f10e501917da0b4
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SEC24A GTSE1 RRBP1 POLQ

7.58e-051975146fe013f98c64b3c5a4e61002254717fb411f8e59
ToppCellmild-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

WDHD1 NDC80 GTSE1 POLQ

7.58e-05197514bd9d57e0c873f6526dca322f4dad8e6bd692586c
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

WDHD1 NDC80 GTSE1 POLQ

7.58e-05197514ffb004c37cdd26cb7cdcd80f769a2eded65416dc
ToppCellHealthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2)

WDHD1 NDC80 GTSE1 POLQ

7.58e-05197514b6bbf87e5823fa66b4cad6a7be4f777356887b59
ToppCellCOVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class

WDHD1 NDC80 GTSE1 POLQ

7.73e-05198514166c000fb0e19602ffdd8bf2b2f19be2c6df96a6
ToppCellnormal_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass

NDC80 RBBP8 GTSE1 POLQ

7.73e-0519851447d572b9db2843aeb2079f33a852babf67270be4
ToppCellsevere_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2)

WDHD1 NDC80 GTSE1 POLQ

7.73e-05198514ed86b0247006befe55400c287d334d2202b470bd
Diseasesleep apnea

KDM2B MACF1

1.79e-0340462EFO_0003877
Diseaseneutrophil percentage of leukocytes

VSTM4 KDM2B CHSY1 FGF13 DTHD1

2.53e-03610465EFO_0007990
Diseasevitamin D measurement, COVID-19

COPB1 HAL

2.67e-0349462EFO_0004631, MONDO_0100096
Diseaselymphocyte percentage of leukocytes

VSTM4 KDM2B CHSY1 FGF13 DTHD1

3.66e-03665465EFO_0007993
Diseaseintellectual disability (implicated_via_orthology)

NDST4 FGF13

6.14e-0375462DOID:1059 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
HSKKRLKPLIPGLRK

BDP1

2526

A6H8Y1
NPPKGALKKLIHAAK

CTAGE3P

116

Q8IX95
NLDDPPKGALKKLIH

CTAGE9

306

A4FU28
LSPSLLQPGKKKHLK

RBBP8

346

Q99708
LQPGKKKHLKTLPFS

RBBP8

351

Q99708
LELILNKPGLKHKPV

AKR1D1

176

P51857
VLKQPPAIAKDKKHL

DOP1A

1881

Q5JWR5
KLKKRGLSPKESLLH

NLRP10

261

Q86W26
TILHLGKSSLPKKPI

COPB1

591

P53618
KPHIDKLLKIGPQLK

MACF1

1961

O94854
LAKHLDKSDPKVKPI

GCN1

1326

Q92616
LLHITKAPKVEKGPL

NDST4

201

Q9H3R1
QKKHGIKLYKPLILP

OXA1L

206

Q15070
KKLKSLGLIHADLKP

HIPK3

311

Q9H422
PVPNKLGLKKTLLKA

GTSE1

286

Q9NYZ3
DPDHLKKLLEKSNPK

ALAS2

306

P22557
PSPEQLKGKILLKGK

PLCD1

426

P51178
HLGKVTLPLAKVKLP

KIF19

936

Q2TAC6
GTHLPPAKVLLSDKK

KCTD18

356

Q6PI47
KKAKLHIQFPKPHPG

EFCAB5

911

A4FU69
IKIHPKKKLPVLLLG

HTRA3

231

P83110
VLEAHGLKPVILKPK

HAL

286

P42357
ALGKKPKAPALRFLK

KDM2B

456

Q8NHM5
KDVLNKLKALHPLPG

POLQ

2181

O75417
GPKSKLKLLHLEKPN

DUSP16

306

Q9BY84
PKSLKILLNPQSHKK

CERKL

166

Q49MI3
KLIKPAALDKPAHKT

CEP162

561

Q5TB80
ICKLPLKLPKHKKLI

DTHD1

646

Q6ZMT9
KKNKPAAHFLPKPLK

FGF13

186

Q92913
KPKHVELNLKTPKNL

CRYBG1

236

Q9Y4K1
KKLALKLHPDKNPNN

DNAJC10

56

Q8IXB1
KLEKPKKYNPGHLLQ

DPPA2

51

Q7Z7J5
HQLLLNPPKKKAILT

PPP6R2

316

O75170
PPKGALKKLIHAAKL

MIA2

916

Q96PC5
LPEHKKKRKGNLPAE

TGIF2LX

46

Q8IUE1
HALPPKKKLPSLKQV

SEZ6L

111

Q9BYH1
LPEHKKKRKGNLPAE

TGIF2LY

46

Q8IUE0
NKAKLPLGLLLHPFK

SEC24A

401

O95486
GPHSVQPLLKHIKKK

TAF1L

651

Q8IZX4
HKEPKDKKINILIPL

CHSY1

526

Q86X52
EKIKKLPLLKGHPQC

TRIM69

101

Q86WT6
LQDLKEKGPTLLKHP

RRBP1

1086

Q9P2E9
IEAHFLPLKKPSIKK

TMEM232

531

C9JQI7
LGKKKKQILHGDPLP

WDHD1

606

O75717
LLSPKPHKQIHTKGK

ZNF705EP

156

A8MWA4
LLSPKPRKQIHTKGK

ZNF705B

156

P0CI00
LLSPKPRKQIHTKGK

ZNF705D

156

P0CH99
LKKLEHPQLTSNPKK

WDR93

231

Q6P2C0
HKPKLLKPQRKVTLP

VSTM4

266

Q8IW00
KHLTALGKLEPKLVP

TUT7

421

Q5VYS8
LGRPKELQPKKLHLC

ZNF263

366

O14978
HKLARKLKLIPKGAE

NDC80

416

O14777